Reply
- PMID: 39957484
- PMCID: PMC12353305
- DOI: 10.1002/art.43135
Reply
Conflict of interest statement
Comment on
-
Hydroxychloroquine dose after hospitalization for systemic lupus erythematosus: comment on the article by Nestor et al.Arthritis Rheumatol. 2025 Sep;77(9):1286-1287. doi: 10.1002/art.43136. Epub 2025 Mar 3. Arthritis Rheumatol. 2025. PMID: 39957430 No abstract available.
- Arthritis Rheumatol.
References
-
- Sulu B, Tascilar K. Hydroxychloroquine dose after hospitalization for SLE: comment on the article by Nestor and colleagues. Arthritis & Rheumatology. 2025. - PubMed
-
- Lee SJ, Silverman E, Bargman JM. The role of antimalarial agents in the treatment of SLE and lupus nephritis. Nat Rev Nephrol. 2011. Oct 18;7(12):718–29. - PubMed
-
- Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases 2019;78:736–745. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources